[1]
Blindheim, A.J. et al. 2021. The use of reTURB in T1 bladder cancer: a Norwegian population-based study. Scandinavian Journal of Urology. 55, 4 (Jul. 2021), 268–274. DOI:https://doi.org/10.1080/21681805.2021.1917652.